Since deacetylation (and deactivation) of p53 itself is regulated by Sirt1, it was hypothesized that the higher activity of p53 in epicardial adipose tissue of CAD patients might be due to the reduction in the expression of Sirt1. This evidence concerns the gene TP53 and coronary artery disorder.